Lista de obras -

Abnormal PcG protein expression in Hodgkin's lymphoma. Relation with E2F6 and NFkappaB transcription factors.

artículo científico publicado en 2004

Action and resistance of monoclonal CD20 antibodies therapy in B-cell Non-Hodgkin Lymphomas

artículo científico

Adverse clinical outcome in Hodgkin's disease is associated with loss of retinoblastoma protein expression, high Ki67 proliferation index, and absence of Epstein-Barr virus-latent membrane protein 1 expression.

artículo científico publicado en 1997

An A91V SNP in the perforin gene is frequently found in NK/T-cell lymphomas

artículo científico publicado en 2014

Analysis of Octamer-Binding Transcription Factors Oct2 and Oct1 and their coactivator BOB.1/OBF.1 in Lymphomas

article

Analysis of the IgVH somatic mutations in splenic marginal zone lymphoma defines a group of unmutated cases with frequent 7q deletion and adverse clinical course

article

Analysis of the frequency of microsatellite instability and p53 gene mutation in splenic marginal zone and MALT lymphomas.

artículo científico publicado en 1998

Analysis of the mutational landscape of classic Hodgkin lymphoma identifies disease heterogeneity and potential therapeutic targets

artículo científico publicado en 2017

Anomalous high p27/KIP1 expression in a subset of aggressive B-cell lymphomas is associated with cyclin D3 overexpression. p27/KIP1-cyclin D3 colocalization in tumor cells.

artículo científico publicado en 1999

Anomalous retinoblastoma protein expression in Sternberg-Reed cells in Hodgkin's disease: a comparative study with p53 and Ki67 expression.

artículo científico publicado en 1996

B-cell lymphoma mutations: improving diagnostics and enabling targeted therapies

artículo científico

Biallelic ATM alterations detected at diagnosis identify a subset of treatment-naïve chronic lymphocytic leukemia patients with reduced overall survival similar to patients with p53 deletion.

artículo científico publicado en 2016

Branched clonal evolution: nodal follicular lymphoma and primary diffuse large B-cell lymphoma of the central nervous system

artículo científico publicado en 2019

Cell cycle deregulation in B-cell lymphomas.

artículo científico publicado en 2002

Chronic lymphocytic leukemia cells in lymph nodes show frequent NOTCH1 activation

artículo científico publicado en 2014

Clonal dynamics monitoring during clinical evolution in chronic lymphocytic leukaemia

artículo científico publicado en 2019

Concordance between circulating tumor cells and clinical status during follow-up in anaplastic lymphoma kinase (ALK) non-small-cell lung cancer patients.

artículo científico publicado en 2017

Deregulated expression of the polycomb-group protein SUZ12 target genes characterizes mantle cell lymphoma.

artículo científico publicado en 2010

Does the presence of hepatitis virus B and C influence the evolution of diffuse large B-cell lymphoma?

artículo científico publicado en 2014

Epstein-Barr virus microRNAs repress BCL6 expression in diffuse large B-cell lymphoma.

artículo científico publicado en 2011

Expression of p21WAF1/CIP1 in fetal and adult tissues: simultaneous analysis with Ki67 and p53.

scientific article published on August 1997

Extreme sensitivity to Yondelis® (Trabectedin, ET-743) in low passaged sarcoma cell lines correlates with mutated p53

artículo científico publicado en 2007

Functional signatures identified in B-cell non-Hodgkin lymphoma profiles.

artículo científico publicado en 2009

Genomic analyses of microdissected Hodgkin and Reed-Sternberg cells: mutations in epigenetic regulators and p53 are frequent in refractory classic Hodgkin lymphoma

article

MDM2 and p21WAF1/CIP1, wild-type p53-induced proteins, are regularly expressed by Sternberg-Reed cells in Hodgkin's disease

artículo científico publicado en 1996

MDM2 expression in lymphoid cells and reactive and neoplastic lymphoid tissue. Comparative study with p53 expression

artículo científico publicado en 1995

Mantle cell lymphoma: transcriptional regulation by microRNAs

artículo científico publicado en 2010

MicroRNA signatures in B-cell lymphomas.

artículo científico publicado en 2012

Molecular basis of targeted therapy in T/NK-cell lymphoma/leukemia: A comprehensive genomic and immunohistochemical analysis of a panel of 33 cell lines

artículo científico publicado en 2017

Molecular heterogeneity in MCL defined by the use of specific VH genes and the frequency of somatic mutations.

artículo científico publicado en 2003

Molecular heterogeneity of splenic marginal zone lymphomas: analysis of mutations in the 5' non-coding region of the bcl-6 gene

scientific article published on 01 April 2001

Mouse cDNA microarray analysis uncovers Slug targets in mouse embryonic fibroblasts

article

Mutated JAK kinases and deregulated STAT activity are potential therapeutic targets in cutaneous T-cell lymphoma.

artículo científico publicado en 2015

Mutational profile of primary breast diffuse large B-cell lymphoma

artículo científico publicado en 2017

Mutations in the JAK/STAT pathway genes and activation of the pathway, a relevant finding in nodal Peripheral T-cell lymphoma.

artículo científico publicado en 2017

NFκB expression is a feature of both activated B-cell-like and germinal center B-cell-like subtypes of diffuse large B-cell lymphoma

artículo científico publicado en 2014

NIK controls classical and alternative NF-κB activation and is necessary for the survival of human T-cell lymphoma cells.

artículo científico publicado en 2013

New drugs and targeted treatments in Hodgkin's lymphoma

artículo científico

Nodal marginal zone lymphoma: gene expression and miRNA profiling identify diagnostic markers and potential therapeutic targets.

artículo científico publicado en 2011

Overall survival in aggressive B-cell lymphomas is dependent on the accumulation of alterations in p53, p16, and p27.

artículo científico publicado en 2001

Overlap at the molecular and immunohistochemical levels between angioimmunoblastic T-cell lymphoma and a subgroup of peripheral T-cell lymphomas without specific morphological features.

artículo científico publicado en 2018

Oxidative phosphorylation induces de novo expression of the MHC class I in tumor cells through the ERK5 pathway.

artículo científico publicado en 2010

PIM kinases as potential therapeutic targets in a subset of peripheral T cell lymphoma cases.

artículo científico publicado en 2014

PLCG1 mutations in cutaneous T-cell lymphomas

artículo científico publicado en 2014

Proliferation centers in chronic lymphocytic leukemia: the niche where NF-κB activation takes place

artículo científico publicado en 2010

Recurrent presence of the PLCG1 S345F mutation in nodal peripheral T-cell lymphomas

artículo científico publicado en 2014

Simultaneous inhibition of pan-phosphatidylinositol-3-kinases and MEK as a potential therapeutic strategy in peripheral T-cell lymphomas.

artículo científico publicado en 2012

Somatic hypermutation signature in B-cell low-grade lymphomas.

artículo científico publicado en 2008

Splenic marginal zone lymphoma: comprehensive analysis of gene expression and miRNA profiling.

artículo científico publicado en 2013

Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study.

artículo científico publicado en 2008

TCL1A expression delineates biological and clinical variability in B-cell lymphoma

artículo científico publicado en 2008

The RHOA G17V gene mutation occurs frequently in peripheral T-cell lymphoma and is associated with a characteristic molecular signature

article

The expression of p53 protein in non-Hodgkin's lymphomas is not always dependent on p53 gene mutations

artículo científico publicado en 1993

The role of miRNAs in the pathogenesis and diagnosis of B-cell lymphomas

artículo científico publicado en 2012

Transcriptional signature of Ecteinascidin 743 (Yondelis, Trabectedin) in human sarcoma cells explanted from chemo-naive patients.

artículo científico publicado en 2005

Transformed follicular lymphoma in the rituximab era: A report from the Spanish Lymphoma Oncology Group

artículo científico publicado en 2019

Two distinct molecular subtypes of chronic lymphocytic leukemia give new insights on the pathogenesis of the disease and identify novel therapeutic targets

artículo científico publicado en 2015

Unique phenotypic profile of monocytoid B cells: differences in comparison with the phenotypic profile observed in marginal zone B cells and so-called monocytoid B cell lymphoma

artículo científico publicado en 2001

Unraveling transformation of follicular lymphoma to diffuse large B-cell lymphoma

artículo científico publicado en 2019

Variability in the expression of polycomb proteins in different normal and tumoral tissues. A pilot study using tissue microarrays

scientific article published on 01 May 2006

p14ARF nuclear overexpression in aggressive B-cell lymphomas is a sensor of malfunction of the common tumor suppressor pathways

artículo científico publicado en 2002

p21WAF1/CIP1 and MDM2 expression in non-Hodgkin's lymphoma and their relationship to p53 status: a p53+, MDM2-, p21-immunophenotype associated with missense p53 mutations

artículo científico publicado en 1997

p53 expression in non-Hodgkin's lymphomas: a marker of p53 inactivation?

artículo científico publicado en 1995

Lista de obras de

Abnormal PcG protein expression in Hodgkin's lymphoma. Relation with E2F6 and NFkappaB transcription factors.

Action and resistance of monoclonal CD20 antibodies therapy in B-cell Non-Hodgkin Lymphomas

Adverse clinical outcome in Hodgkin's disease is associated with loss of retinoblastoma protein expression, high Ki67 proliferation index, and absence of Epstein-Barr virus-latent membrane protein 1 expression.

An A91V SNP in the perforin gene is frequently found in NK/T-cell lymphomas

Analysis of Octamer-Binding Transcription Factors Oct2 and Oct1 and their coactivator BOB.1/OBF.1 in Lymphomas

Analysis of the IgVH somatic mutations in splenic marginal zone lymphoma defines a group of unmutated cases with frequent 7q deletion and adverse clinical course

Analysis of the frequency of microsatellite instability and p53 gene mutation in splenic marginal zone and MALT lymphomas.

Analysis of the mutational landscape of classic Hodgkin lymphoma identifies disease heterogeneity and potential therapeutic targets

Anomalous high p27/KIP1 expression in a subset of aggressive B-cell lymphomas is associated with cyclin D3 overexpression. p27/KIP1-cyclin D3 colocalization in tumor cells.

Anomalous retinoblastoma protein expression in Sternberg-Reed cells in Hodgkin's disease: a comparative study with p53 and Ki67 expression.

B-cell lymphoma mutations: improving diagnostics and enabling targeted therapies

Biallelic ATM alterations detected at diagnosis identify a subset of treatment-naïve chronic lymphocytic leukemia patients with reduced overall survival similar to patients with p53 deletion.

Branched clonal evolution: nodal follicular lymphoma and primary diffuse large B-cell lymphoma of the central nervous system

Cell cycle deregulation in B-cell lymphomas.

Chronic lymphocytic leukemia cells in lymph nodes show frequent NOTCH1 activation

Clonal dynamics monitoring during clinical evolution in chronic lymphocytic leukaemia

Concordance between circulating tumor cells and clinical status during follow-up in anaplastic lymphoma kinase (ALK) non-small-cell lung cancer patients.

Deregulated expression of the polycomb-group protein SUZ12 target genes characterizes mantle cell lymphoma.

Does the presence of hepatitis virus B and C influence the evolution of diffuse large B-cell lymphoma?

Epstein-Barr virus microRNAs repress BCL6 expression in diffuse large B-cell lymphoma.

Expression of p21WAF1/CIP1 in fetal and adult tissues: simultaneous analysis with Ki67 and p53.

Extreme sensitivity to Yondelis® (Trabectedin, ET-743) in low passaged sarcoma cell lines correlates with mutated p53

Functional signatures identified in B-cell non-Hodgkin lymphoma profiles.

Genomic analyses of microdissected Hodgkin and Reed-Sternberg cells: mutations in epigenetic regulators and p53 are frequent in refractory classic Hodgkin lymphoma

MDM2 and p21WAF1/CIP1, wild-type p53-induced proteins, are regularly expressed by Sternberg-Reed cells in Hodgkin's disease

MDM2 expression in lymphoid cells and reactive and neoplastic lymphoid tissue. Comparative study with p53 expression

Mantle cell lymphoma: transcriptional regulation by microRNAs

MicroRNA signatures in B-cell lymphomas.

Molecular basis of targeted therapy in T/NK-cell lymphoma/leukemia: A comprehensive genomic and immunohistochemical analysis of a panel of 33 cell lines

Molecular heterogeneity in MCL defined by the use of specific VH genes and the frequency of somatic mutations.

Molecular heterogeneity of splenic marginal zone lymphomas: analysis of mutations in the 5' non-coding region of the bcl-6 gene

Mouse cDNA microarray analysis uncovers Slug targets in mouse embryonic fibroblasts

Mutated JAK kinases and deregulated STAT activity are potential therapeutic targets in cutaneous T-cell lymphoma.

Mutational profile of primary breast diffuse large B-cell lymphoma

Mutations in the JAK/STAT pathway genes and activation of the pathway, a relevant finding in nodal Peripheral T-cell lymphoma.

NFκB expression is a feature of both activated B-cell-like and germinal center B-cell-like subtypes of diffuse large B-cell lymphoma

NIK controls classical and alternative NF-κB activation and is necessary for the survival of human T-cell lymphoma cells.

New drugs and targeted treatments in Hodgkin's lymphoma

Nodal marginal zone lymphoma: gene expression and miRNA profiling identify diagnostic markers and potential therapeutic targets.

Overall survival in aggressive B-cell lymphomas is dependent on the accumulation of alterations in p53, p16, and p27.

Overlap at the molecular and immunohistochemical levels between angioimmunoblastic T-cell lymphoma and a subgroup of peripheral T-cell lymphomas without specific morphological features.

Oxidative phosphorylation induces de novo expression of the MHC class I in tumor cells through the ERK5 pathway.

PIM kinases as potential therapeutic targets in a subset of peripheral T cell lymphoma cases.

PLCG1 mutations in cutaneous T-cell lymphomas

Proliferation centers in chronic lymphocytic leukemia: the niche where NF-κB activation takes place

Recurrent presence of the PLCG1 S345F mutation in nodal peripheral T-cell lymphomas

Simultaneous inhibition of pan-phosphatidylinositol-3-kinases and MEK as a potential therapeutic strategy in peripheral T-cell lymphomas.

Somatic hypermutation signature in B-cell low-grade lymphomas.

Splenic marginal zone lymphoma: comprehensive analysis of gene expression and miRNA profiling.

Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study.

TCL1A expression delineates biological and clinical variability in B-cell lymphoma

The RHOA G17V gene mutation occurs frequently in peripheral T-cell lymphoma and is associated with a characteristic molecular signature

The expression of p53 protein in non-Hodgkin's lymphomas is not always dependent on p53 gene mutations

The role of miRNAs in the pathogenesis and diagnosis of B-cell lymphomas

Transcriptional signature of Ecteinascidin 743 (Yondelis, Trabectedin) in human sarcoma cells explanted from chemo-naive patients.

Transformed follicular lymphoma in the rituximab era: A report from the Spanish Lymphoma Oncology Group

Two distinct molecular subtypes of chronic lymphocytic leukemia give new insights on the pathogenesis of the disease and identify novel therapeutic targets

Unique phenotypic profile of monocytoid B cells: differences in comparison with the phenotypic profile observed in marginal zone B cells and so-called monocytoid B cell lymphoma

Unraveling transformation of follicular lymphoma to diffuse large B-cell lymphoma

Variability in the expression of polycomb proteins in different normal and tumoral tissues. A pilot study using tissue microarrays

p14ARF nuclear overexpression in aggressive B-cell lymphomas is a sensor of malfunction of the common tumor suppressor pathways

p21WAF1/CIP1 and MDM2 expression in non-Hodgkin's lymphoma and their relationship to p53 status: a p53+, MDM2-, p21-immunophenotype associated with missense p53 mutations

p53 expression in non-Hodgkin's lymphomas: a marker of p53 inactivation?